Skip to main content
. 2023 Jan 5;15(2):363. doi: 10.3390/cancers15020363

Figure 1.

Figure 1

PDAC patients showed increased levels of monocytes. Gating strategy for circulating monocytes (A); percentage of circulating monocytes in healthy individuals, PDAC and pancreatitis patients (B); percentage of monocytes in PDAC patients correlated to the lymph node status (pN), perineural invasion (Pn), tumor grading (G) and the resection status (R) (C); percentage of monocytes (5% identified by minimal p-value approach) defining the risk for G3 and Pn+ PDAC patients (D); survival analysis for patients with high (>5%) vs. low (≤5%) monocytes (E); * p < 0.05; ** p < 0.01; ns no significance.